Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis
about
A friend within the heart: natriuretic peptide receptor signalingTranscription factor MITF regulates cardiac growth and hypertrophyIntermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.A gene therapy approach for long-term normalization of blood pressure in hypertensive mice by ANP-secreting human skin graftsCardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction.Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during developmentThe functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigmsGenetic variation in the natriuretic peptide system and heart failure.Regulation of cardiac angiotensin-converting enzyme and angiotensin AT1 receptor gene expression in Npr1 gene-disrupted miceHyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and ratsProBNP-derived peptides in cardiac disease.Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.Pharmacological inhibition of soluble epoxide hydrolase provides cardioprotection in hyperglycemic rats.Relaxin and atrial natriuretic peptide pathways participate in the anti-fibrotic effect of a melon concentrate in spontaneously hypertensive rats.Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular RegulationGenetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner.Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.NPR-A regulates self-renewal and pluripotency of embryonic stem cells.TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway.Natriuretic peptides in ectopic myocardial tissues originating from mouse embryonic stem cells.Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.Functional properties of bone marrow derived multipotent mesenchymal stromal cells are altered in heart failure patients, and could be corrected by adjustment of expansion strategies.Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension.Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.Mechanisms through which bradykinin promotes glomerular injury in diabetes.Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts.Heterozygous deletion of sarcolipin maintains normal cardiac function.Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy.Effects of streptozotocin-induced diabetes and physical training on gene expression of extracellular matrix proteins in mouse skeletal muscle.K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts.Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure.C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling.BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors.Responses of the trout cardiac natriuretic peptide system to manipulation of salt and water balance.Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure.Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.P2Y(4) nucleotide receptor: a novel actor in post-natal cardiac development.Characterizing the role of atrial natriuretic peptide signaling in the development of embryonic ventricular conduction system.
P2860
Q24300973-9DAD9E4F-09D5-4B10-B10D-D664BB16877DQ24676288-E0606609-6896-46BB-B369-9DB59CE93115Q30477341-F8052F87-4D24-47D7-B8B0-AC2D8D8C0E25Q33357303-22BF0C68-8BE3-4927-BE60-04ECC4357D79Q33667103-C6CB047D-3532-484B-B1BA-37DA18409324Q33803183-FA2A936C-7CE0-46F9-994F-3ED8E0C0D1C2Q33950331-D8E9E6CE-3604-4926-AB11-ACF1800BA7CAQ34990330-7281603E-A82E-4F4A-8B6B-7EB629E5CD84Q35046791-4877A481-09D8-4889-938A-05A655E0416DQ35050007-0B189B3C-FDFD-4F2E-B934-ED21623FB0A9Q35829973-C85D0BF5-71D2-4D18-9123-D83ACC9D5095Q35847164-9AEE2E06-B2C4-4BAA-9BF2-4FA04F80D6CCQ35936915-0BFA9039-CB02-49B1-8A93-51B9E73F714FQ36312752-2F8DB42E-C2A2-4AC8-88E4-2053A112D56BQ36799613-794F2BC7-1EF9-4034-BAB4-4F8ADD8C4B33Q37117338-E789BBAA-5228-4A77-9320-C4149372CE25Q37336602-6E32C6FB-22D0-4EBA-A6AE-F20498573E2DQ37594085-3DD995B5-2D1A-45FA-A1DC-D9558917E428Q38317272-79E6BB97-D0A6-4D40-AEEE-9E71EC64A763Q39578469-F0506755-4F29-4E50-B845-7106F120995DQ40365592-A1D87683-A324-46D2-83EB-B40C309C4825Q40423614-EB576F42-6BD5-446E-A341-D5B0059D8B92Q41511312-8D7EFF79-BD02-468E-AF5F-9DF1ECC18D3DQ42017721-AF0835BF-2139-4364-874E-AF13A19899E2Q42376539-5FE870E4-F069-41C9-B786-272FEDBD2FE2Q42475794-00C7E7D7-C248-40E1-AB68-FA32838B2A99Q45251388-09D74A3B-9935-4069-8854-502EBFF62AD3Q46322063-9A6D3CC9-5343-4D30-B655-8242BFB0CBB0Q46421083-BCDE460F-6F59-486A-B48B-5C59841C67D4Q46792345-A19C8553-0206-438E-A8E0-2D4583B20D5DQ46849831-06B63AC9-CE9F-4689-864C-E0F0AE7802A9Q46954153-FFCD5B1D-8878-44BB-9B0A-77B6A36790F1Q47641198-B0B8F0F5-DCD0-43A1-A8D6-1E3B8C1EAC1EQ48318699-6C39694B-A93C-40D6-BCBE-B89881C7EBFBQ48417679-F275F8C0-78BD-4143-949B-391B46592771Q48783244-27E66665-70F1-4E98-BE7B-DE160898A295Q49663322-C8110439-2C3D-4075-AE4B-650CD90ECBD2Q52579764-C61F1993-60AC-4031-9A8F-B3BBD48DF35FQ54318064-4895E18F-6580-4923-BB34-CD3067E2AB94Q54979872-5DF1817E-A296-4471-AA2E-B2C51A9DB5EE
P2860
Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Ventricular expression of natr ...... rdiac hypertrophy and fibrosis
@ast
Ventricular expression of natr ...... rdiac hypertrophy and fibrosis
@en
type
label
Ventricular expression of natr ...... rdiac hypertrophy and fibrosis
@ast
Ventricular expression of natr ...... rdiac hypertrophy and fibrosis
@en
prefLabel
Ventricular expression of natr ...... rdiac hypertrophy and fibrosis
@ast
Ventricular expression of natr ...... rdiac hypertrophy and fibrosis
@en
P2093
P2860
P1476
Ventricular expression of natr ...... rdiac hypertrophy and fibrosis
@en
P2093
J W Knowles
Leigh J Ellmers
V A Cameron
P2860
P304
P356
10.1152/AJPHEART.00677.2001
P577
2002-08-01T00:00:00Z